Lobbying disclosures · Lobbying report
COR: second_quarter 2026 lobbying report
Issues related to trade Issues related to health care and pharmaceutical industry
Follow COR- Became public
- Jul 20, 2026, 3:35 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 12:48 PM EST
Why this is connected
Exact legal-name match: Cencora, Inc. (https://www.sec.gov/Archives/edgar/data/1140859/).
Reported lobbying amounts
Income: $75,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/33818bd1-da4d-4cc2-85e0-aee9959be1d8/","filing_uuid":"33818bd1-da4d-4cc2-85e0-aee9959be1d8","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/33818bd1-da4d-4cc2-85e0-aee9959be1d8/print/","filing_document_content_type":"text/html","income":"75000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"David J. Schiappa","dt_posted":"2026-07-20T15:35:52-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW","registrant_address_2":"Suite 825","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":12675,"url":"https://lda.gov/api/v1/registrants/12675/","house_registrant_id":31811,"name":"THE DUBERSTEIN GROUP INC.","description":"Consulting","address_1":"325 7th Street NW","address_2":"Suite 825","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID J. SCHIAPPA","contact_telephone":"+1 202-728-1100","dt_updated":"2026-07-24T11:16:57.603169-04:00"},"client":{"id":66748,"url":"https://lda.gov/api/v1/clients/66748/","client_id":66748,"name":"CENCORA, INC.","general_description":"American drug wholesale company and a contract research organization.","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-04-15"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to trade","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":79182,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"R","last_name":"HOWARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to health care and pharmaceutical industry","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":79182,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"R","last_name":"HOWARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71388,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":"KATE","middle_name":"WINKLER","last_name":"KEATING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101351,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"KELLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59537,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"J","last_name":"SCHIAPPA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in COR
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
Traded 14 days before earnings - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026
Got $1K from the company’s PAC - Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026 · Dependent
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 31, 2026 · disclosed Apr 30, 2026
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 23, 2026 · disclosed Apr 30, 2026
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 23, 2026 · disclosed Apr 30, 2026 · Dependent
Got $1K from the company’s PAC
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.